What is SINT's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.02B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for SINT?

P/E (TTM) is n/a and 52-week range is $1.40 to $4.64 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s SINT figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for SINT?

The company profile lists revenue (TTM) near $2M, net income (TTM) near $-1.44B, EPS (TTM) near $-3.03 when available from the market-data feed. Figures are informational and may lag live markets.

Where is SINTX Technologies Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Salt Lake City, Utah, US, 6.2M shares outstanding, ISIN US8293927039 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

SINTX Technologies Inc

$SINT

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$2.07

-2.82%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 32 full-time employees. The company went IPO on 2014-02-11. The company is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. The company has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. The company manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.

Employees

Website

sintx.com/

IPO

2014-02-11

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)